Clinical Trials Sponsored by Hai-Jun Wang

Total 493 results

Hai-Jun Wang

Completed

Body Constitution Classification Based Comprehensive Health Management Intervention on Obese Population

Obesity | Overweight

China
Hai-Jun Wang

Completed

Study on Obesity Intervention With Physical Exercise Among Students in Changping District, Beijing

Pediatric Obesity
Zhen Jun Wang

Recruiting

Sleeve Gastrectomy With Reestablishment of the Acute Angle of His (SG-REACH) in Obese Patients (SG-REACH)

Gastroesophageal Reflux Disease | Sleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Angle of His

China
Zhen Jun Wang

Unknown

Sleeve Gastrectomy With Uncut Jejunal Bypass (SG-uncut JJB) Verus Sleeve Gastrectomy in Obese Patients

Sleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | Uncut

China
Zhen Jun Wang

Completed

Anal Fistula Plug, a Retrospective Study

Recurrence | Complication | Healing Rate

China
Jun Wang

Recruiting

Thymosin Alpha-1 for irAE Secondary to ICIs

IrAE

China
WANG KAI

Recruiting

Clinical Efficacy and Mechanism of High Definition tDCS Based on dmPFC in the Intervention of Chronic Insomnia

Chronic Insomnia | Transcranial Direct Current Stimulation

China
WANG KAI

Completed

Effect of Intermittent Theta Burst Stimulation (iTBS) for Alleviating Symptoms of Schizophrenia Patients

Schizophrenia | Transcranial Magnetic Stimulation | Functional Magnetic Resonance Imaging

China
Hao Tang

Recruiting

Deep Learning Reconstruction Algorithms in Dual Low-dose CTA

Deep Learning

China
Jie-Jun Wang

Active, not recruiting

Helicobacter Pylori Eradication to Prevent Gastric Cancer

Stomach Neoplasms | Helicobacter Infections

China
Jian-jun Yang

Completed

Functional Magnetic Resonance Imaging (fMRI) of Brain in ICU Survivors With Cognitive Impairment

Inflammation | Septic Shock | Cognitive Impairment | Functional Magnetic Resonance Imaging

China
Fang Jun

Completed

The Role of Remazolam in Reducing the Incidence of Postoperative Delirium in Elderly Patients

Postoperative Delirium

China
Jian-jun Yang

Completed

Dezocine for Prevention of Catheter-related Bladder Discomfort

Catheter Related Bladder Discomfort

China
Jian-jun Yang

Unknown

Long-term Outcomes of Critical Illness Survivors

Intensive Care Units

China
Kai-Yang Lv

Unknown

Virtual Reality Technology to Alleviate the Acute Pain of Scar Treatment With Fractional Laser Under Local Anesthesia

Acute Pain | Scar

China
Wen-Kai Weng

Completed

Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma

Multiple Myeloma | Blood Cancer

United States
Sang Hak Lee

Unknown

Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid (AVOCADO)

Mixed Hyperlipidemia

Korea, Republic of
Jun Wang

Completed

the Effect of Different Drugs and Infusion Ways on Degree of Postoperative Comfort

Analgesia, Patient-Controlled

China
Chunxiao Wang

Completed

Corneal Epithelial Allograft From Living-related Donor for LSCD

Limbal Stem Cell Deficiency

China
Chunxiao Wang

Unknown

Corneal Epithelial Autograft for Limbal Dermoid

Corneal Dermoid

China
Chunxiao Wang

Unknown

Corneal Epithelial Autograft for LSCD

Limbal Stem Cell Deficiency

China
Chunxiao Wang

Unknown

Corneal Epithelial Autograft for Pterygium

Pterygium

China
wang shusen

Unknown

The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia

Breast Cancer

China
wang shusen

Recruiting

Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy (SMA-BC-002)

Breast Neoplasms

China
wang shusen

Recruiting

Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer

Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer

China
wang shusen

Recruiting

Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

Breast Cancer

China
wang shusen

Recruiting

Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial

Triple Negative Breast Cancer

China
wang shusen

Not yet recruiting

PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy

Breast Cancer | Brain Metastasis

China
Xueding Wang
Sun Yat-sen University

Unknown

A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment

Gastrointestinal Stromal Tumors | Somatic Mutation | Plasma Concentration | Germline Mutation

China
Chunxiao Wang

Unknown

Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis

Herpes Simplex Keratitis

China
Bai Jun

Unknown

Gefitinib Combined With Thalidomide to Treat NSCLC

NSCLC
Chong Kun Dang Pharmaceutical

Not yet recruiting

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome (PRISTINE)

Metabolic Syndrome | Essential Hypertension
Chong Kun Dang Pharmaceutical

Recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia

Androgenetic Alopecia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Not yet recruiting

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

Cardiovascular Diseases

Korea, Republic of
Chong Kun Dang Pharmaceutical

Recruiting

Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes

Type2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition

Endocrine, Nutritional and Metabolic Diseases

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150

Type 2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg

Hypertension

Korea, Republic of
Chong Kun Dang Pharmaceutical

Active, not recruiting

Study to Evaluate the Safety and Pharmacokinetics of CKD-379

Type II Diabetes Mellitus

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics and Safety/Tolerability of CKD-379

Type II Diabetes Mellitus

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects (CKD-371)

Type II Diabetes Mellitus

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects

Hypertension

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930

Glaucoma

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

Type II Diabetes Mellitus

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

Type II Diabetes Mellitus

Korea, Republic of

3

Subscribe